Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review Edith A. PerezChau DangJavier Cortes Review 19 May 2022 Pages: 1 - 11
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis Alexandra GiatromanolakiAnastasia G. GkegkaMichael Koukourakis Preclinical study 28 April 2022 Pages: 13 - 23
Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients Elizabeth Lerner PapautskyMartha CarlsonMaryam B. Lustberg Preclinical study Open access 14 May 2022 Pages: 25 - 33
Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer Julia E. McGuinnessVicky RoKatherine D. Crew Preclinical study 16 May 2022 Pages: 35 - 47
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study Caroline BomanLuisa Edman KesslerTheodoros Foukakis Clinical trial Open access 24 April 2022 Pages: 49 - 56
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer Mario E. LacoutureShari B. GoldfarbJulie E. Lang Clinical trial Open access 26 April 2022 Pages: 57 - 64
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers Karen S. AndersonTimothy K. ErickBeth Overmoyer Clinical trial 28 April 2022 Pages: 65 - 78
Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE) Bhavika K. PatelKay PepinRichard Ehman Clinical trial 30 April 2022 Pages: 79 - 89
Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study Doris M. HowellKelly MetcalfeMay Lynne Quan Epidemiology 24 April 2022 Pages: 91 - 102
Effect of estradiol as a continuous variable on breast cancer survival by menopausal status: a cohort study in China Junxian LiChenyang LiKexin Chen Epidemiology 25 April 2022 Pages: 103 - 111
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy Brenna C. McDonaldKathleen Van DykAndrew J. Saykin Epidemiology 27 April 2022 Pages: 113 - 126
Hypertensive diseases of pregnancy and risk of breast cancer in the Black Women’s Health Study Zahna BighamYvonne RoblesKimberly A. Bertrand Epidemiology 28 April 2022 Pages: 127 - 135
Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ Melissa Anne MalloryKarissa WhitingMelissa L. Pilewskie Epidemiology 29 April 2022 Pages: 137 - 148
Serum hormone levels and normal breast histology among premenopausal women Mark E. ShermanThomas de BelJeroen van der Laak Epidemiology 03 May 2022 Pages: 149 - 158
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study Mark van BareleAmy RiebornMaartje J. Hooning Epidemiology Open access 04 May 2022 Pages: 159 - 170
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer Divya A. ParikhLisa KodyJennifer L. Caswell-Jin Epidemiology 11 May 2022 Pages: 171 - 178
CBCRisk-Black: a personalized contralateral breast cancer risk prediction model for black women Ibrahim Hossain SajalMarzana ChowdhurySwati Biswas Epidemiology 13 May 2022 Pages: 179 - 186
Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region Siham Chafai ElalaouiFatima Zohra LaarabiAbdelaziz sefiani Epidemiology 17 May 2022 Pages: 187 - 198
Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting Parinita Keshav SwarnkarKefah Mokbel Letter to the Editor 03 May 2022 Pages: 199 - 199
